ArticleLeukemia2026

Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Guru Subramanian Guru Murthy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.